Related Experiment Video
Updated: Dec 8, 2025
09:56
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
1.1K
New trends in cellular therapy.
Hideyuki Okano1,2, Doug Sipp3,2,4,5
1Keio University School of Medicine, Department of Physiology, 35 Shinano-machi, Shinjuku-ku, Tokyo 160-8582, Japan hidokano@a2.keio.jp.
Development (Cambridge, England)
|September 18, 2020
Summary
Regenerative medicine advances focus on cellular therapies using pluripotent stem cells (PSCs). This review highlights clinical trials of induced (i)PSC-derived cells and discusses challenges for iPSC-based therapies.
Area of Science:
- Regenerative medicine
- Stem cell biology
- Cellular therapy
Background:
- Regenerative therapies aim to restore tissue and organ function.
- Cellular therapies are a key component of regenerative medicine.
- Pluripotent stem cells (PSCs) offer potential for cell replacement strategies.
Purpose of the Study:
- To summarize recent progress in cellular therapies.
- To highlight clinical trial advancements using induced pluripotent stem cells (iPSCs).
- To discuss challenges and safety considerations for iPSC-based cell therapies.
Main Methods:
- Review of current literature on PSC-based regenerative therapies.
- Analysis of the status of clinical trials involving iPSC-derived cells.
- Discussion of safety profiles and manufacturing challenges.
Main Results:
- Significant progress has been made in generating various cell types from iPSCs.
- Several iPSC-based clinical trials are underway for different diseases.
- Key challenges include ensuring cell product consistency, efficacy, and long-term safety.
Conclusions:
- iPSC-based cell therapies hold great promise for treating a range of conditions.
- Addressing safety concerns and optimizing manufacturing are crucial for clinical translation.
- Continued research and development are essential for the success of iPSC therapies.
More Related Videos
07:33Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
Published on: September 19, 2025
568
06:10Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
Published on: May 9, 2025
765
Related Concept Videos
01:27Tumor Immunotherapy
1.4K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.4K
01:21Stem Cell Therapy for Tissue Regeneration
4.5K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.5K
02:57Targeted Cancer Therapies
8.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.4K
01:24Methods of Nuclear Reprogramming
2.0K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.0K
02:49Cancer Therapies
9.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.6K
01:28Forced Transdifferentiation
2.2K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
2.2K